Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.43
Delayed Data
As of May 25
 +0.0601 / +2.54%
Today’s Change
2.00
Today|||52-Week Range
5.18
+1.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues121.7M175.9M140.9M146.1M
 
 
 
 
 
Cost of Goods Sold45.2M51.4M43.2M44.5M
 
 
 
 
 
Depreciation And Amortization33.0M94.7M86.2M73.3M
 
 
 
 
 
 
Operating ExpensesGross Income43.6M29.7M11.4M28.2M
 
 
 
 
 
General Expenses66.1M102.8M104.9M77.6M
 
 
 
 
 
Research And Development3.9M8.2M6.1M787.0K
 
 
 
 
 
Total Operating Expenses144.2M248.9M234.4M195.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.5M-73.0M-93.5M-49.4M
 
 
 
 
 
Extraordinary Credit0.0019.5M20.6M26.2M
 
 
 
 
Extraordinary Charge-7.3M-49.0M-57.5M-18.6M
 
 
 
 
 
Interest Expense On Debt19.1M38.3M37.9M37.0M
 
 
 
 
 
Other Expenses-401.0K-582.0K-823.0K2.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-49.0M-141.3M-169.2M-76.8M
 
 
 
 
 
Income Taxes-13.7M-7.1M-439.0K-373.0K
 
 
 
 
 
Net Income-35.3M-148.3M-169.6M-77.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.8M5.3M7.8M10.7M
 
 
 
 
 
Shares To Calculate EPS Diluted3.8M5.3M7.8M10.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.30-$27.80-$21.67-$7.21
 
 
 
 
 
EPS Diluted-$9.30-$27.80-$21.67-$7.21